According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs: Perrigo Company (PRGO), Northrop Grumman Corporation (NOC), Roche Holding Ltd. (RHHBY), Nexen Inc. (NXY) and Pfizer Inc. (PFE).
Perrigo Company (PRGO) Reached the 52-Week High of $117.94
The prices of Perrigo Company shares have reached $117.94, which is 1.7% off the 52-week high of $119.97. Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Perrigo Company has a market cap of $11.21 billion; its shares were traded at around $117.94 with a P/E ratio of 24 and P/S ratio of 3.5. The dividend yield of Perrigo Company stocks is 0.3%. Perrigo Company had an annual average earnings growth of 19.5% over the past 10 years. GuruFocus rated Perrigo Company the business predictability rank of 2-star.
On Aug. 16, Perrigo Company reported results for the fourth fiscal quarter of 2012. Net sales for the fourth quarter of fiscal 2012 were approximately $832 million, an increase of 18% compared to last year. Excluding the charges outlined in Table I at the end of this release, fourth quarter fiscal 2012 adjusted income from continuing operations was $121 million, or $1.28 per diluted share, up from $95 million, or $1.02 per diluted share, a year ago.
This month, Executive Vice President and CFO Judy L. Brown, Chairman Joseph C. Papa and Senior Vice President and CIO Thomas Farrington sold shares of PRGO stock. Executive Vice President General Counsel Todd W Kingma sold shares in September and Senior Vice President Commercial Business Development Jeffrey Needham sold shares in August.
Northrop Grumman Corporation (NOC) Reached the 52-Week High of $68.82
The prices of Northrop Grumman Corporation shares have reached $68.82, which is 1.4% off the 52-week high of $69.75. Northrop Grumman Corporation is a high technology company providing innovative solutions in systems integration, defense electronics and information technology for its U. Northrop Grumman Corporation has a market cap of $17.16 billion; its shares were traded at around $68.82 with a P/E ratio of 9.7 and P/S ratio of 0.7. The dividend yield of Northrop Grumman Corporation stocks is 3.2%. Northrop Grumman Corporation had an annual average earnings growth of 9.8% over the past 10 years. GuruFocus rated Northrop Grumman Corporation the business predictability rank of 3-star.
On July 25, Northrop Grumman Corporation reported second quarter 2012 earnings from continuing operations of $480 million, or $1.88 per diluted share, compared with $520 million, or $1.81 per diluted share, in the second quarter of 2011. On a pension-adjusted basis, earnings per diluted share from continuing operations increased 13 percent to $1.79 from $1.59. During the quarter the company repurchased 4.9 million shares of its common stock for approximately $295 million;$1.1 billion remains on its current share repurchase authorization.
In July, Chairman, CEO and President Wesley G. Bush bought 1,000 shares of NOC stock. In August, Corporate Vice President and General Counsel Sheila C. Cheston, Corporate Vice President and President Aerospace Systems Gary W. Ervin, Corporate Vice President and President Electronic Systems James F. Pitts and Corporate Vice President and President Aerospace Systems Gary W. Ervin sold shares.
Roche Holding Ltd. (RHHBY) Reached the 52-Week High of $48.87
The prices of Roche Holding Ltd. shares have reached $48.87, which is 0.5% off the 52-week high of $49.1. Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. Roche Holding Ltd. has a market cap of $169.43 billion; its shares were traded at around $48.87 with and P/S ratio of 3.6. The dividend yield of Roche Holding Ltd. stocks is 3.1%. Roche Holding Ltd. had an annual average earnings growth of 17.9% over the past 10 years.
Nexen Inc. (NXY) Reached the 52-Week High of $25.83
The prices of Nexen Inc. shares have reached $25.83, which is 0.7% off the 52-week high of $26. Nexen Inc. is an independent, Canadian-based global energy company. Nexen Inc. has a market cap of $13.51 billion; its shares were traded at around $25.83 with a P/E ratio of 17.6 and P/S ratio of 2.1. The dividend yield of Nexen Inc. stocks is 0.8%. Nexen Inc. had an annual average earnings growth of 12.6% over the past 10 years. GuruFocus rated Nexen Inc. the business predictability rank of 2-star.
Nexen Inc. recently reported second quarter 2012 operating and financial results and provided an update on strategic priorities. Production volumes averaged 213,000 barrels of oil equivalent per day (boe/d), a 5% increase from the first quarter. Cash flow from operations was up 6% to $707 million ($1.34 per share). Net income decreased 36% from the prior quarter to $109 million ($0.20 per share) primarily due to the previously announced unsuccessful Kakuna exploration well in the Gulf of Mexico.
Pfizer Inc. (PFE) Reached the 52-Week High of $25.1
The prices of Pfizer Inc. shares have reached $25.1, which is 1.7% off the 52-week high of $25.52. Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. Pfizer Inc. has a market cap of $190.62 billion; its shares were traded at around $25.1 with a P/E ratio of 11 and P/S ratio of 2.8. The dividend yield of Pfizer Inc. stocks is 3.5%. Pfizer Inc. had an annual average earnings growth of 0.5% over the past 10 years.
On July 31, Pfizer Inc. reported financial results for second-quarter 2012. Second-quarter 2012 revenues were $15.1 billion, a decrease of 9% compared with $16.5 billion in the year-ago quarter, which reflects an operational decline of $977 million, or 6%, and the unfavorable impact of foreign exchange of $451 million, or 3%. For second-quarter 2012, U.S. revenues were $5.7 billion, a decrease of 15% compared with the year-ago quarter. International revenues were $9.3 billion, a decrease of 5% compared -2- with the prior-year quarter, primarily due to the unfavorable impact of foreign exchange.